The estimated Net Worth of Christopher Paul Simms is at least 2.06 百万$ dollars as of 2 January 2023. Mr Simms owns over 6,250 units of IVERIC bio Inc stock worth over 1,390,140$ and over the last 3 years he sold ISEE stock worth over 0$. In addition, he makes 668,251$ as Sr. VP & Chief Commercial Officer at IVERIC bio Inc.
Mr has made over 3 trades of the IVERIC bio Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 6,250 units of ISEE stock worth 249,688$ on 2 January 2023.
The largest trade he's ever made was exercising 33,750 units of IVERIC bio Inc stock on 2 August 2022 worth over 1,348,313$. On average, Mr trades about 7,178 units every 68 days since 2021. As of 2 January 2023 he still owns at least 34,797 units of IVERIC bio Inc stock.
You can see the complete history of Mr Simms stock trades at the bottom of the page.
Christopher Paul Simms is the Sr. VP & Chief Commercial Officer at IVERIC bio Inc.
As the Sr. VP & Chief Commercial Officer of IVERIC bio Inc, the total compensation of Mr Simms at IVERIC bio Inc is 668,251$. There are 8 executives at IVERIC bio Inc getting paid more, with Glenn Sblendorio having the highest compensation of 2,462,150$.
Mr Simms is 46, he's been the Sr. VP & Chief Commercial Officer of IVERIC bio Inc since . There are 12 older and 1 younger executives at IVERIC bio Inc. The oldest executive at IVERIC bio Inc is Calvin Roberts, 67, who is the Independent Director.
Christopher's mailing address filed with the SEC is C/O IVERIC BIO, INC., 8 SYLVAN WAY, PARSIPPANY, NJ, 07054.
Over the last 6 years, insiders at IVERIC bio Inc have traded over 8,677,595$ worth of IVERIC bio Inc stock and bought 130,569 units worth 624,325$ . The most active insiders traders include Glenn Sblendorio、Venture Capital Iv, L.P.Ver...、Keith Westby. On average, IVERIC bio Inc executives and independent directors trade stock every 15 days with the average trade being worth of 848,338$. The most recent stock trade was executed by Keith Westby on 3 July 2023, trading 20,000 units of ISEE stock currently worth 58,800$.
we are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (amd).
IVERIC bio Inc executives and other stock owners filed with the SEC include: